Clarivate sells its LS&H segment for $600M to cut debt and boost margins. CLVT stock trades higher as core business focus sharpens.

Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million

Clarivate sells its LS&H segment for $600M to cut debt and boost margins. CLVT stock trades higher as core business focus sharpens.